FMC BioPolymer AS
FMC Corporation is one of the world’s leading specialty chemical companies. We are proud that our chemistries are helping to grow the world’s food, enabling new innovations in pharmaceutical delivery, enhancing foods and beverages, contributing to a more sustainable energy supply, facilitating the remediation of our environment, and advancing the manufacture of hundreds of essential products. Please visit www.fmc.com to learn more about FMC.
FMC Health and Nutrition has more than 75 years experience with biopolymers, and a deep understanding of the complexity of product formulations. We work side-by-side with customers within the health and nutrition area to meet unique needs and challenges and uphold the highest standards of safety, quality, efficacy and value. More information about our activities can be found at www.fmcbiopolymer.com.
FMC BioPolymer AS is a part of FMC Health and Nutrition, and has two sites in Norway: The alginate manufacturing site located in Karmøy close to Haugesund at the West Coast of Norway, and the NovaMatrix business unit located in Sandvika close to Oslo.
The FMC activities in Norway are related to manufacturing of alginate from brown seaweeds. This includes the harvesting of seaweeds along the coast of Norway. More information can be found at www.stortare.no.
NovaMatrixTM, a business unit of FMC BioPolymer, produces and supplies well-characterized and documented ultrapure bio-compatible and bio-absorbable biopolymers for use in the pharmaceutical, biotechnology and biomedical industries, including applications such as drug delivery, tissue engineering, cell encapsulation, and medical devices. Our products include ultrapure grades of sodium alginate, water-soluble chitosan salts, and sodium hyaluronates that fulfill functional and regulatory requirements. More information at www.NovaMatrix.biz.
We manufacture PRONOVATM sodium alginate and PROTASANTM chitosan salts in Sandvika, Norway in accordance with GMP guidelines; ICH Q7; and ISO standards: ISO 9001:2008, ISO 13485:2003 and ISO 22442:2007. Our Sodium Hyaluronate Pharma Grade is produced by our strategic partner, Kikkoman Biochemifa Company (KBC), formerly Kibun Food Chemifa, in Kamogawa, Japan under GMP guidelines; Article 13 of the Pharmaceutical Law of Japan and ISO standards; ISO 9001:2008 and ISO 14001:2004. For these products we maintain drug master files with the US FDA.
NOVATACH peptide-coupled alginates and NOVAFECT oligomeric chitosans are classified as research products as they have not yet been proven to be safe for human use.
In addition to supplying ultrapure biopolymers, NovaMatrix develops applications technology relating to the use of our products and secures the intellectual property rights covering those applications. These rights are typically licensed to customers, often in connection with joint development or R&D agreements. We also will manufacture customized products under development agreements on request.
Our new NovaMatrixTM 3-D cell culture system is based on alginate foam and expands research possibilities in regenerative medicine.